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Abstract 
Background: Isoflurane and sevoflurane protect lungs with ischemia–reperfusion (IR) injury. We examined the influ-
ence of desflurane on IR lung injury using isolated rabbit lungs perfused with a physiological salt solution.
Methods: The isolated lungs were divided into three groups: IR, desflurane-treated ischemia–reperfusion (DES-IR), 
and ventilation/perfusion-continued control (Cont) groups (n = 6 per group). In the DES-IR group, inhalation of 
desflurane at 1 minimum alveolar concentration (MAC) was conducted in a stable 30-min phase. In the IR and DES-IR 
groups, ventilation/perfusion was stopped for 75 min after the stable phase. Subsequently, they were resumed. Each 
lung was placed on a balance, and weighed. Weight changes were measured serially throughout this experiment. The 
coefficient of filtration (Kfc) was determined immediately before ischemia and 60 min after reperfusion. Furthermore, 
bronchoalveolar lavage fluid (BALF) was collected from the right bronchus at the completion of the experiment. After 
the completion of the experiment, the left lung was dried, and the lung wet-to-dry weight ratio (W/D) was calculated.
Results: The Kfc values at 60 min after perfusion were 0.40 ± 0.13 ml/min/mmHg/100 g in the DES-IR group, 
0.26 ± 0.07 ml/min/mmHg/100 g in the IR group, and 0.22 ± 0.08 (mean ± SD) ml/mmHg/100 g in the Cont group. 
In the DES-IR group, the Kfc at 60 min after the start of reperfusion was significantly higher than in the other groups. In 
the DES-IR group, W/D was significantly higher than in the Cont group. In the DES-IR group, the BALF concentrations 
of nitric oxide metabolites were significantly higher than in the other groups. In the DES-IR group, the total amount of 
vascular endothelial growth factor in BALF was significantly higher than in the Cont group.
Conclusions: The pre-inhalation of desflurane at 1 MAC exacerbates pulmonary IR injury in isolated/perfused rabbit 
lungs.
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Background
Many studies reported that volatile anesthetics play a 
protective role against myocardial ischemia–reperfusion 
injury. The cardioprotective actions of these anesthetics 
are stated in the “ACC/AHA Guidelines for Periopera-
tive Cardiovascular Assessment and Management after 
Non-cardiac Surgery” (Fleisher et al. 2007). Some articles 
have also reported the protective actions of volatile anes-
thetics against pulmonary ischemia–reperfusion injury 
(Liu et al. 1999, 2000).
Ischemia–reperfusion injury of the organs occurs 
through anoxia-reoxygenation. Anoxia rapidly decreases 
the level of adenosine triphosphate (ATP), leading to 
the generation of hypoxanthine. Reoxygenation pro-
motes the production of reactive oxygen species, such 
as superoxide, hydrogen peroxide, and hydroxyradicals 
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by hypoxanthine, inducing organ injury (de Perrot et al. 
2003; Janero et al. 1991; Ambrosio et al. 1991).
In the lungs, the alveoli contain oxygen; therefore, 
oxygen deficiency does not occur rapidly. In the cardiac 
muscle, ATP level decreases to 50% within 6  min after 
circulatory arrest (Kolocassides et al. 1995). For lung tis-
sue inflated with room air, 1.5  h are required until the 
ATP level decreases to 50% despite circulatory arrest 
(De Leyn et  al. 1993). The pathogenesis of pulmonary 
ischemia–reperfusion injury differs from that of cardiac 
ischemia–reperfusion injury. Briefly, pulmonary blood 
flow disruption stimulates mechanoreceptors of the pul-
monary vascular endothelial cells, causing lung injury 
through lipid peroxidation in these cells (de Perrot et al. 
2003).
Lung tissue is more complex than cardiac muscle, 
consisting of the vascular endothelium and alveolar epi-
thelium (de Perrot et  al. 2003; Egan 2004). Pulmonary 
ischemia–reperfusion injury refers to damage of the 
pulmonary vascular endothelium and alveolar epithe-
lium. Alveolar macrophages activated in the presence of 
ischemia–reperfusion release inflammatory cytokines (de 
Perrot et  al. 2003). The influence of volatile anesthetics 
on pulmonary and cardiac ischemia–reperfusion injury 
may differ.
In a rat experimental model of neurogenic pulmonary 
edema, isoflurane exacerbated pulmonary edema by 
inducing the release of vascular endothelial growth fac-
tor (VEGF) in the vascular endothelium (Kandatsu et al. 
2005); neurogenic pulmonary edema was caused by sym-
pathetic excitement. Desflurane has a chemical formula 
similar to that of isoflurane (Eger 1987), but it has more 
potent stimulatory effects on the sympathetic nerve than 
isoflurane (Weiskopf et al. 1994). In addition, the blocked 
thoracic aorta causes oxidative stress in the entire organ-
ism through ischemia and subsequently pulmonary vas-
cular permeability, which is exacerbated by desflurane 
(Nielsen et al. 1998). In addition, in pigs under mechani-
cal ventilation, desflurane (1 minimum alveolar concen-
tration [MAC]) inhalation caused oxidative stress in the 
lungs and induced the apoptosis of lung cells (Allaouch-
iche et  al. 2001; Kalimeris et  al. 2011). In the present 
study, we hypothesized that desflurane could exacerbate 
increased vascular permeability in ischemic reperfusion 
injured lungs through sympathetic stimulatory effects, 
and examined this hypothesis using isolated perfused 
rabbit lungs. Vascular hyperpermeability was evaluated 
based on the capillary coefficient of filtration (Kfc).
Methods
Isolated perfused lung preparation
The experimental protocol was approved by the Tottori 
University Laboratory Animal Care Committee. Isolated 
rabbit lungs were prepared using the method described 
in detail by Liu et  al. (1999) with minor modifications. 
Male New Zealand White rabbits weighing 1.9–2.6  kg 
were used. The lungs were ventilated with 93.5% air and 
6.5% CO2 (tidal volume 6 ml/kg; frequency 40/min; posi-
tive end-expiratory pressure 2  cmH2O) and perfused 
with bicarbonate-buffered physiologic salt solution [PSS 
(in mM): NaCl, 119; KCl, 4.7; MgSO4, 1.17; NaHCO3, 
22.61; KH2PO4, 1.18; CaCl2, 3.2] in a recirculating man-
ner at a constant flow rate of 30  ml/kg/min. To each 
100 ml of PSS stock solution, we added 100 mg dextrose, 
20  mU insulin, and 5  g hydroxyethylstarch (Ajinomoto 
Pharmaceuticals, Tokyo, Japan). Pulmonary arterial pres-
sure (PPA), left atrium pressure (PLA), and airway pressure 
(PAW) were monitored continuously via side ports in the 
respective cannula. The partial pressure of carbon diox-
ide (PCO2) in the perfusate was adjusted to 35–40 mmHg 
during the experiment by continuous aeration of the 
reservoir liquid surface using mixed gas with the same 
composition as the inspired gas. The empyreal part of the 
reservoir was covered with Saran Wrap®, and the liquid 
surface of the reservoir was separated from air. Gas anal-
ysis of the perfusate was performed during the experi-
ment, and a small amount of sodium bicarbonate was 
added to the perfusate to maintain the pH at 7.35–7.45.
The lungs were removed en bloc and enclosed in a 
humidified chamber which was positioned on an elec-
tronic scale (GX4000; A and D, Tokyo, Japan) to allow 
continuous monitoring of lung weight. PLA was set at 
2 mmHg (referenced at the hilum), and the whole system 
was equilibrated at 37 °C. A flow probe (FF-050T; Nihon 
Kohden, Tokyo, Japan) connected to an electromagnetic 
flow meter (MFV-3100; Nihon Kohden, Tokyo, Japan) 
was placed in the perfusion circuit for the continuous 
monitoring of blood flow (Q). Total pulmonary vascular 
resistance (Rt) was calculated using the following for-
mula: Rt = (PPA − PLA)/Q.
Coefficient of filtration
Pulmonary vascular permeability was evaluated by 
determining the pulmonary capillary Kfc in accordance 
with the Starling equation (Drake et al. 1978). First, iso-
gravimetric pressure (PISO) was measured as described 
by Thompson et  al. (1997): the shunt between the pul-
monary and left atrial cannulae was opened and perfu-
sion was discontinued, and changes in lung weight were 
observed by gradually increasing the reservoir height and 
pulmonary capillary pressure (PPC) to determine maxi-
mum PPC without any increase in lung weight, i.e. PISO. 
The PPC was then changed to equal PISO +7  mmHg by 
rapidly elevating the reservoir to a height corresponding 
to +7  mmHg, and the reservoir was kept at this height 
for 7 min. The rate of lung weight gain every minute from 
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2 to 6 min was then recorded on a semilogarithmic plot 
and extrapolated to time 0 by linear regression. The loga-
rithm of lung weight gain at time 0 was converted to an 
antilog, and the resulting value was used to calculate Kfc.
Kfc was normalized using the baseline wet lung weight 
and expressed in mL/min/mmHg/100 g lung tissue. The 
baseline wet lung weight was calculated from the body 
weight (BW) of the animals using the formula: BW 
(g) × 0.0024 (Seeger et al. 1986).
Although positive pressure ventilation was interrupted 
during the Kfc determination, a constant flow of the 
mixed gas was administered at 3 cmH2O of PAW.
Wet‑to‑dry weight ratio
The left lung was excised at the end of the experiment 
and its wet weight was measured. The left lung was dried 
at 85 °C under a heating lamp for 30 h and its dry weight 
was measured to determine lung water weight compared 
with pulmonary tissue weight to determine the wet-to-
dry weight ratio (W/D) using the formula: W/D =  (wet 
weight − dry weight)/dry weight.
Bronchoalveolar lavage fluid analysis
The right lung was used for BALF preparation at the 
end of the experiment. Four aliquots (5 ml each) of iso-
tonic sodium chloride solution were instilled separately 
through the trachea and drained. The collected fluid was 
centrifuged immediately at 250×g and 4  °C for 10  min. 
The supernatant was divided into several aliquots and 
stored at −80 °C until analysis.
The concentration of nitric oxide (NO) metabolites 
(sum of NO3− and NO2−) was determined using a high-
performance liquid chromatography system (Shimadzu, 
Tokyo, Japan) with visible light absorbance detection at 
546 nm, as described by Green et al. (1982).
Lactate dehydrogenase (LDH) concentration was meas-
ured using a clinical chemistry analyzer (JCA-BM8060, 
Japan Electron Optics Laboratory, Tokyo, Japan). The 
lower detection limit was 6 IU/l.
Superoxide dismutase (SOD) activity was measured by 
the modified nitrite method, as described by Oyanagui 
(1984).
Interleukin (IL)-6 concentration was measured using a 
fully automated chemiluminescent enzyme immunoassay 
system (Lumipulse F, Fujirebio Inc., Tokyo, Japan). The 
lower detection limit was 0.2 pg/ml.
VEGF concentration was measured using an enzyme 
immune assay (EIA) kit (hVEGF QKit, R&D Systems Inc., 
Minneapolis, USA). As the concentration of VEGF in 
BALF reduces through a pulmonary edema fluid-related 
dilutional effect, we compared the total amount of VEGF 
in each BALF sample (Cross and Matthay 2011; Bhargava 
and Wendt 2012; Ware et al. 2005).
Experimental protocol
The isolated lungs selected were those that (1) had a 
homogenous white appearance without signs of hemo-
stasis or edema formation, and (2) were isogravimetric in 
the equilibration period of 30 min.
The isolated lungs were divided into three groups. In 
the control (Cont) group (n = 6), the isolated lungs were 
continuously perfused and ventilated after an equili-
bration period for 135  min. In the ischemia–reperfu-
sion (IR) group (n =  6), ventilation and perfusion were 
interrupted (ischemia) after an equilibration period for 
75  min, and the isolated lungs were maintained in the 
humidified chamber at 37 °C while PAW was maintained 
at 3.5 cmH2O by administrating a constant flow of mixed 
gas. Gas at the same concentration and flow rate as used 
in the equilibration period was added to the liquid sur-
face of the reservoir. The empyreal part of the reservoir 
was covered with Saran Wrap®, and the liquid surface 
of the reservoir was separated from the air. The pulmo-
nary arterial and left atrial cannula were both opened to 
the atmosphere, resulting in an intravascular pressure of 
0  mmHg during ischemia. The isolated lungs were rep-
erfused and reventilated for 60  min after ischemia. The 
flow velocity at the start of reperfusion was increased 
slowly to 30  ml/kg/min, so that the PPA did not exceed 
20 mmHg. At the start of reventilation, the positive end-
expiratory pressure was established as 10  cmH2O for a 
few respirations until atelectasis was macroscopically 
relieved, but the same respiratory conditions as adopted 
in the equilibration period were used thereafter. In the 
desflurane-treated ischemia–reperfusion (DES-IR) group 
(n = 6), 1 MAC [1 MAC = 8.9% for rabbits (Loer et al. 
1995)] desflurane was administered for 30 min during the 
equilibration period, then ischemia was performed for 
75 min, followed by 60 min reperfusion and reventilation, 
which was the same as that for the IR group.
In a preliminary experiment, the pre-inhalation of des-
flurane at 1.5 MAC was performed. At the start of reper-
fusion, edema fluid appeared in a tracheal tube before the 
flow rate reached 30 ml/kg/min, and it was impossible to 
continue the protocol. In this experiment, the inhalation 
concentration of desflurane was established as 1 MAC.
Desflurane (Baxter International Inc., Chicago, IL) 
was administered using a desflurane vaporizer (D-Vapor, 
Dräger Medical GmbH, Lübeck, Germany). The concen-
tration of desflurane in inspired gas was monitored using 
a bedside monitor (BSM-2301, Nihon Kohden, Tokyo, 
Japan).
Kfc was determined in the IR and DES-IR groups at 
baseline (end of the equilibration period) and 60  min 
after the start of reperfusion. Rt, PAW, and lung weight 
gain were determined in the IR and DES-IR groups at 
baseline and at 10, 20, 30, 40, 50, and 60  min after the 
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start of reperfusion. These values were determined in 
the Cont group at the same intervals. When edema 
fluid appeared in a tracheal tube before the flow velocity 
reached 30 ml/kg/min at the start of reperfusion, the Kfc 
and wet left lung weight were measured at that point, and 
BALF was collected from the right lung. The experiment 
was then completed.
Statistical analysis was performed using Prism 5 
(Graph Pad Software, San Diego, CA). All data are pre-
sented as the mean ± standard deviation (SD). Changes 
in Kfc, Rt, lung weight gain, and Paw were evaluated using 
two-way factorial analysis of variance (ANOVA) followed 
by the post hoc Bonferroni test. Changes in NO metab-
olites, LDH, SOD, IL6, and VEGF in the BALF and the 
W/D were evaluated using one-way factorial ANOVA or 
Kruskal–Wallis test followed by post hoc Tukey test or 
Dunn’s test. Significance was determined at P < 0.05.
Results
In the DES-IR group, there was an isolated lung prepa-
ration in which edema fluid appeared in a tracheal tube 
before the flow velocity reached 30  ml/kg/min at the 
time of reperfusion. In this preparation, it was impos-
sible to measure the Rt, PAW, and lung weight gain after 
reperfusion.
Coefficient of filtration
The Kfc values at 60  min after reperfusion were 
0.40 ±  0.13 ml/min/mmHg/100 g in the DES-IR group, 
0.26  ±  0.07  ml/min/mmHg/100  g in the IR group, and 
0.22 ± 0.08 ml/min/mmHg/100 g in the Cont group. In 
the DES-IR group, the Kfc at 60 min after reperfusion was 
significantly higher than in the IR (P  <  0.05) and Cont 
(P  <  0.01) groups. It was significantly higher than the 
baseline (P < 0.0001) (Fig. 1).
Wet‑to‑dry weight ratio
The W/D ratios were 12.2  ±  3.3 in the DES-IR group, 
9.3  ±  0.9 in the IR group, and 7.8  ±  1.1 in the Cont 
group. In the DES-IR group, the W/D was significantly 
higher than in the Cont group (P < 0.01) (Fig. 2).
Physiological parameters analysis
The DES-IR group consisted of 5 isolated lung prepara-
tions, and the other two groups consisted of 6 each.
In the DES-IR group, the lung weight gain at 10, 20, 
30, 40, 50, and 60 min after the start of reperfusion was 
significantly higher than in the Cont group (P  <  0.05, 
P < 0.01, P < 0.001, P < 0.001, P < 0.0001, and P < 0.0001, 
respectively). In this group, the lung weight gain at 20, 
30, 40, 50, and 60 min after the start of reperfusion was 
significantly higher than the baseline (P < 0.01, P < 0.001, 
P  <  0.001, P  <  0.0001, and P  <  0.0001, respectively) 
(Fig. 3a).
In the DES-IR group, the Rt at 10  min after reperfu-
sion was significantly higher than in the Cont group 
(P  <  0.0001). In the DES-IR and IR groups, there were 
significant increases in Rt 10  min after reperfusion in 
comparison with the baseline (P < 0.0001, and P < 0.01, 
respectively) (Fig. 3b).
In the DES-IR group, the PAW at 20, 30, 40, 50, and 
60  min after the start of reperfusion was significantly 
higher than in the Cont group (P < 0.05, P < 0.01, P < 0.01, 
P  <  0.01, and P  <  0.01, respectively). In this group, the 
PAW at 60 min after the start of reperfusion was signifi-
cantly higher than the baseline (P < 0.05) (Fig. 3c).
Bronchoalveolar lavage fluid analysis
The NO metabolite concentrations in BALF were 
11.0 ± 4.0 μM in the DES-IR group, 5.2 ± 1.3 μM in the 
IR group, and 6.5  ±  2.7  μM in the Cont group. In the 
DES-IR group, the BALF concentrations of NO metab-
olites were significantly higher than in the Cont and IR 
groups (P < 0.05, and P < 0.01, respectively) (Fig. 4).
In the DES-IR group, the BALF concentration of 
LDH was significantly higher than in the other groups 
Fig. 1 Changes in the coefficient of filtration (Kfc). Data are 
mean ± SD (n = 6 per group). δP < 0.0001 versus baseline. *P < 0.05 
versus DES-IR group. †P < 0.01 versus DES-IR group
Fig. 2 Changes in lung wet-to-dry weight ratio (W/D). Data are 
mean ± SD (n = 6 per group). †P < 0.01 versus DES-IR group
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(P < 0.05). In all samples of BALF belonging to the Cont 
and IR groups, the concentrations of LDH were below 
the detection limit (Fig. 5).
The SOD activity in BALF was 3.8 ±  1.1  U/ml in the 
DES-IR group, 4.0  ±  1.2  U/ml in the IR group, and 
3.9 ± 1.2 U/ml in the Cont group. There were no signifi-
cant differences in SOD activity in BALF among the three 
groups (Fig. 6).
In all samples of BALF belonging to the three groups, 
the BALF concentrations of IL-6 were below the detec-
tion limit (Fig. 7).
The total amounts of VEGF in BALF were 6.5 ± 4.3 ng 
in the DES-IR group, 3.5 ±  1.3 ng in the IR group, and 
2.0 ± 1.0 ng in the Cont group. In the DES-IR group, the 
total amount of VEGF in BALF was significantly higher 
than in the Cont group (P < 0.05). It was slightly higher 
than in the IR group, although there was no statistical dif-
ference (Fig. 8).
Discussion
Using isolated/perfused rabbit lungs, we examined the 
influence of desflurane on lungs with ischemia–reperfusion 
injury. In the DES-IR group, Kfc at 60  min after the start 
of reperfusion was significantly higher than the baseline. 
It was also significantly higher than in the other groups. 
In addition, W/D in the DES-IR group at the completion 
of this experiment was significantly higher than in the 
Cont group. Furthermore, the BALF concentrations of NO 
metabolites were also significantly higher than in the other 
groups. In the DES-IR group, the total amount of VEGF in 
BALF was significantly higher than in the Cont group.
The mechanism of neurogenic pulmonary edema 
involves the marked enhancement of the sympathetic 
nerves. Kandatsu et  al. (2005) reported that pre-treat-
ment inhalation of 1.5% isoflurane exacerbated neu-
rogenic pulmonary edema in a rat in  vivo neurogenic 
pulmonary edema model. This was because isoflurane 
Fig. 3 Physiological parameters after reperfusion (n = 6 per group). One of six experiments in the DES-IR group was terminated because of severe 
lung edema within 10 min after the start of reperfusion. Therefore, the data from this animal were removed from the analysis. Data are mean ± SD. 
a Lung weight gain. b Rt: total pulmonary vascular resistance. c PAW: airway pressure. *P < 0.05 versus Cont group. 
†P < 0.01 versus Cont group. 
‡P < 0.001 versus Cont group. §P < 0.0001 versus Cont group. αP < 0.05 versus baseline. βP < 0.01 versus baseline. γP < 0.001 versus baseline. 
δP < 0.0001 versus baseline
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stimulated VEGF release by pulmonary vascular endothe-
lial cells. The vascular permeability-enhancing action of 
VEGF was 50,000 times stronger than that of histamine 
(Dvorak et al. 1995). VEGF receptors are also present in 
the alveolar epithelium (Maniscalco et al. 1997).
An in  vivo experiment using hairless albino guinea 
pigs demonstrated that the vascular permeability-
enhancing action mechanism of VEGF involved the 
VEGF-induced release of NO and prostacyclin in the 
vascular endothelium (Murohara et  al. 1998). Another 
experiment using cultured vascular endothelial cells 
from the bovine microcirculatory system also showed 
that the vascular endothelial cells produced NO and 
prostacyclin in the presence of VEGF stimulation 
(Murohara et al. 1998).
Desflurane is a halogenated methyl ethyl ether, simi-
lar to isoflurane. The structural formulae of desflurane 
and isoflurane differ in the halogen atom bound to the 
α carbon atom of the ethyl group, which chlorine in iso-
flurane and fluorine in desflurane (Eger 1987). Isoflurane 
and desflurane have common characteristics, such as 
concentration-dependent sympathomimetic effects. In 
healthy adult volunteers, the sympathomimetic effects 
of desflurane were more marked than those of isoflurane 
(Weiskopf et al. 1994).
In this experiment, in the DES-IR group, vascu-
lar resistance after reperfusion was high, and the total 
weight of VEGF in BALF was significantly higher than in 
the Cont group, and slightly higher than in the IR group. 
In addition, the concentrations of NO metabolites in 
BALF were higher than in the other groups. In addition, 
the pre-inhalation of desflurane potentiated ischemia–
reperfusion injury-related pulmonary vascular hyperper-
meability. This was possibly because desflurane induced 
the release of VEGF by pulmonary vascular endothelial 
cells through a mechanism similar to that of isoflurane.
We used the release of LDH into the BALF as an esti-
mate of cell damage during the experiment. At the com-
pletion of this experiment, the BALF concentration of 
LDH in the DES-IR group was higher than in the other 
groups. This indicated not only the decreased functions 
of the vascular endothelium, but also damage to lung tis-
sue (Nielsen et al. 1998).
Kandatsu et  al. (2005) reported that the pre-inha-
lation of 1.5% isoflurane exacerbated neurogenic pul-
monary edema by inducing the release of VEGF in 
vascular endothelial cells in a rat in  vivo neurogenic 
pulmonary edema model, whereas pre-inhalation of 
Fig. 4 Changes in nitric oxide (NO) metabolite (sum of nitrite and 
nitrate) concentrations in bronchoalveolar lavage fluid (BALF). Data 
are mean ± SD (n = 6 per group). *P < 0.05 versus DES-IR group. 
†P < 0.01 versus DES-IR group
Fig. 5 Changes in lactate dehydrogenase (LDH) concentration 
in bronchoalveolar lavage fluid (BALF). (LDH concentrations in all 
samples of BALF from the Cont and IR groups were lower than the 
detection level). Data are mean ± SD (n = 6 per group). *P < 0.05 
versus other groups
Fig. 6 Changes in superoxide dismutase (SOD) activity in bronchoal-
veolar lavage fluid (BALF) (n = 6 per group). Data are mean ± SD. 
There were no significant differences among the three groups (NS 
not significant)
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2.5% sevoflurane reduced pulmonary edema without 
inducing VEGF release. In a study using perfused rat 
lungs, the pre-inhalation of isoflurane at 1 MAC pro-
tected against pulmonary vascular hyperpermeability 
after warm ischemia–reperfusion, but the protective 
effects of isoflurane at 3 MAC were weak (Fujinaga et al. 
2006). This was possibly because isoflurane at 3 MAC 
inhibited cyclic guanosine monophosphate production, 
increasing vascular resistance at 10 min after ischemia–
reperfusion. According to another study, in pigs under 
mechanical ventilation, the inhalation of desflurane at 1 
MAC increased the concentration of malondialdehyde 
(MDA) in BALF, whereas sevoflurane at 1 MAC did not 
increase it (Allaouchiche et al. 2001). Volatile inhalation 
anesthetics have both damaging and protective effects 
on the lungs depending on their types and inhalation 
concentrations.
Several methods can be employed to quantify the 
microvascular damage caused by ischemia–reperfu-
sion injury. The most reliable is a histological examina-
tion of the lungs, which allows a detailed examination of 
the region and extent of damage. However, this method 
does not provide sufficient quantitative data on the func-
tional status of the microvascular barrier. In contrast, Kfc, 
measured in isogravimetric conditions, can be reliably 
and reproducibly determined in the isolated and per-
fused lungs of dogs, rabbits, rats, and guinea pigs. Kfc has 
been measured in isolated and perfused lungs in studies 
on various reperfusion injuries and microvessels in other 
lung injuries (Liu et  al. 2000; Thompson et  al. 1997). A 
high Kfc value reflects high capillary permeability. In the 
present study, Kfc also corresponded to W/D.
The present study had some limitations, as described 
below. In this experiment using perfused rabbit lungs, 
the levels of IL-6 in BALF in the three groups were 
below the detection limit. Kotani et  al. reported that 
volatile inhalation anesthetics increased the BALF lev-
els of tumor necrosis factor-α and macrophage inflam-
matory protein 2, as an inflammatory cytokine, in rats 
on mechanical ventilation, whereas the BALF level of 
IL-6 was below the detection limit, showing no change 
(Kotani et  al. 1999). Chung et  al. (2013) indicated that 
the homogenized lung tissue level of IL-6 increased 
using a rat lipopolysaccharide-induced lung injury 
model. IL-6 is released by macrophages, lymphocytes, 
vascular endothelial cells, fibroblasts, and mast cells 
(Liu et  al. 2007). It may have been necessary to meas-
ure the lung tissue level of IL-6 in this experiment. In 
our experiment, the SOD activity in BALF remained 
unchanged even after desflurane inhalation. In an 
in  vivo experiment with rabbits, desflurane (1 MAC) 
inhalation enhanced pulmonary vascular permeability 
by oxidants released by the transient blocking of the 
thoracic aorta and reduced the ascorbic acid content in 
lung tissue (Nielsen et al. 1998). Ascorbic acid is a bio-
logical antioxidant. In pigs under artificial respiration, 
desflurane (1 MAC) inhalation resulted in oxidative 
stress in the lungs, induced the apoptosis of lung cells, 
and increased the MDA concentration in BALF, but 
caused no change in SOD activity (Allaouchiche et  al. 
2001; Kalimeris et  al. 2011). In this experiment with 
rabbits, MDA concentrations in BALF should have been 
measured. In addition, Liu et  al. (2000) demonstrated 
the protective effects of sevoflurane on ischemia–reper-
fusion injuries of isolated perfused lungs of rats, but not 
of rabbits. Thus, in the present study, the same experi-
ment should have been conducted with sevoflurane. In 
addition, to further demonstrate that VEGF-stimulated 
NO release increased vascular permeability, the effects 
Fig. 7 Changes in interleukin (IL)-6 concentration in bronchoalveo-
lar lavage fluid (BALF). Data are mean ± SD (n = 6 per group). IL-6 
concentrations in all samples of BALF from the three groups were less 
than detection level
Fig. 8 Changes in total amount of vascular endothelium growth 
factor (VEGF) in bronchoalveolar lavage fluid (BALF). Data are 
mean ± SD (n = 6 per group). *P < 0.05 versus DES-IR group
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of desflurane on the vascular permeability of ischemia–
reperfusion injured lungs pretreated with NO-inhib-
itors, such as L-NAME, should have been examined. 
Furthermore, histological changes in the ischemia–rep-
erfusion injured lungs, caused by desflurane, should 
have been examined.
Among volatile anesthetics, desflurane shows the most 
potent protective actions on cardiac muscle (Piriou et al. 
2002). In cardiac surgery using cardiopulmonary bypass 
(CPB), desflurane may be used for myocardial protection. 
However, CPB poses a risk of pulmonary ischemia–rep-
erfusion injury. Thus, the use of desflurane at a high con-
centration in cardiac surgery using CPB may cause lung 
injuries.
Conclusions
We investigated the influence of desflurane on the lungs 
with ischemia–reperfusion injury using isolated/per-
fused rabbit lungs. The pre-inhalation of desflurane 
exacerbated ischemia–reperfusion-induced pulmonary 
vascular hyperpermeability and pulmonary damage.
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